MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma

Acta Gastro-Enterologica Belgica

Volumn 76, Issue 4, 2013, Pages 386-392

  Sun, Liping ^a   Hu, Jingqiong ^a   Xiong, Wei ^a   Chen, Xiaomei ^a   Li, Huiyu ^a   Jie, Shenghua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatocellular carcinoma (HCC); MicroRNAs (miRNAs); Microvesicles (MVs); Target genes

Indexed keywords

MICRORNA; MICRORNA 127; MICRORNA 432; MICRORNA 671 5P; NUCLEAR MATRIX PROTEIN; NUCLEOLAR PROTEIN 3; SERINE ARGININE REPETITIVE MATRIX 1 PROTEIN; SERINE ARGININE RICH PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; RNA;

ARTICLE; BIOINFORMATICS; CHRONIC HEPATITIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HEPATITIS B; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MEMBRANE VESICLE; MICROARRAY ANALYSIS; MICROVESICLE; MOLECULAR GENETICS; PREDICTION; UPREGULATION; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CIRCULATION; LIVER TUMOR; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; ULTRASTRUCTURE; VASCULARIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER CIRCULATION; LIVER NEOPLASMS; MALE; MICRORNAS; MICROSCOPY, ELECTRON; MICROVESSELS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, NEOPLASM; YOUNG ADULT;

EID: 84897940847     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bosch F.X., Ribes J., Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis., 1999, 19: 271-285.
2. Zhou L., Wang C.P., Lu Y.Y., Bai W.L., Qu J.H., Lou M. et al. Decrease in size of non-treated lesions after cryoablation for hepatocellular carcinoma. Hepatogastroenterology, 2012, 59: 252-254.
3. Yu S.C., Yeung D.T., So N.M. Imaging features of hepatocellular carcinoma. Clin. Radiol., 2004, 59: 145-156.
4. Thomas M.B., Abbruzzese J.L. Opportunities for targeted therapies in hepatocellular carcinoma. J. Clin. Oncol., 2005, 23: 8093-8108.
5. Wolf P. Thenature and significance of platelet products in human plasma. Br. J. Haematol., 1967, 13: 269-288.
6. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell. Sci., 2010, 123: 1603-1611.
7. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A. et al. Intercellular transfer of the oncogenic receptor egfrviii by microvesicles derived from tumour cells. Nat. Cell. Biol., 2008, 10: 619-624.
8. Martins V.R., Dias M.S., Hainaut P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr. Opin. Oncol., 2013, 25: 66-75.
9. Sun W., Julie Li Y.S., Huang H.D., Shyy J.Y., Chien S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu. Rev. Biomed. Eng., 2010, 12: 1-27.
10. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D. et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838.
11. Qi J., Wang J., Katayama H., Sen S., Liu S.M. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma, 2013, 60 (2): 135-42.
12. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P. et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood, 2000, 95: 930-935.
13. Braconi C., Henry J.C., Kogure T., Schmittgen T., Patel T. The role of micrornas in human liver cancers. Semin. Oncol., 2011, 38: 752-763.
14. Borel F., Konstantinova P., Jansen P.L.M. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. Journal of Hepatology, 2012, 56: 1371-1383.
15. Loffler D., Brocke-Heidrich K., Pfeifer G., Stocsits C., Hackermuller J., Kretzschmar A.K. et al. Interleukin-6 dependent survivalof multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood, 2007, 110: 1330-1333.
16. Goga A., Benz C. Anti-oncomir suppression of tumor phenotypes. Mol. Interv., 2007, 7: 199-202.
17. Yu G.R., Kim S.H., Park S.H., Cui X.D., Xu D.Y., Yu H.C. et al. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma. Exp. Mol. Med., 2007, 39: 641-652.
18. Cho S.J., Kim Y.J., Surh Y.J., Kim B.M., Lee S.K. Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells. J. Biol. Chem., 2011, 286: 199662-199671.
19. Gu Y., Lin S., Li J.L., Nakagawa H., Chen Z., Jin B. et al. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene, 2012, 31: 469-479.
20. Starmann J., Fälth M., Spindelböck W. et al. Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis. PLoS One, 2012, 7: e46584.
21. Ward J.J., Sodhi J.S., McGuffin L.J., Buxton B.F., Jones D.T. Prediction and Functional Analysis of Native Disorder in Proteins from the Three Kingdoms of Life. J. Mol. Biol., 2004, 337: 635-645.
22. Patil M.A., Chua M.S., Pan K.H., Lin R., Lih C.J., Cheung S.T. et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene, 2005, 24: 3737-3747.
23. Tovar V., Alsinet C., Villanueva A., Hoshida Y., Chiang D. Y., Solé M. et al. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol., 2010,52: 550-559.
24. Xiong W., SUN L.P., CHEN X.M., LI H.Y., JIE S.H. Comparison of microRNAexpression profile in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC. J. Huazhong U SCI-MED., 2013, 33: 645-648.
25. Xu J., Zhu X., Wu L., Yang R., Yang Z., Wang Q. et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int., 2012, 32: 752-760.
26. Calvisi D.F., Ladu S., Gorden A., Farina M., Conner E.A., Lee J.S. et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology, 2006, 130: 1117-1228.